Looking to publish in CNS & Neurological Disorders - Drug Targets? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCNS & Neurological Disorders - Drug Targets is a journal focused on CNS and neurological disorders and drug targets. It publishes themed issues and is indexed in Scopus, SCI Expanded, and MEDLINE/PubMed. The journal lists an Impact Factor of 3 and states that open access articles are also available on ScienceDirect.
Looking to publish in CNS & Neurological Disorders - Drug Targets? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
CNS & Neurological Disorders - Drug Targets accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Mini-Reviews
Systematic Reviews
Meta-Analyses
Research Articles
Randomized Drug Clinical Trial Studies
Short Communications
Letters
Case Reports
Recent Publications
Overview of the Mechanistic Potential of Serotonin Reuptake Transporters in Depression
Sonia Singh, Kirti Baghel, Ashima Ahuja, Keshav Bansal
Unraveling Shared Molecular Mechanisms in Alzheimer's, Parkinson's, and Neuropathic Pain: Targeting p38 MAPK and Wnt/β-Catenin Pathways
Anjali Bhardwaj, Neha Parveen, Rajesh Singh, Bharat Bhushan
Aging-driven Mechanisms Underlying Parkinson’s Disease Pathogenesis: Molecular, Cellular, and Systemic Perspectives
Amanda Yee Jing Lee, Leanne Khoo, Khuen Yen Ng, Cien Leong Chye, Jia Yee Lee, Yi Ko, Soi Moi Chye
Prolactin and Neuroendocrine Regulation in Brain Injury: Mechanisms of Adaptive Plasticity and Therapy Strategies
Prashant Tiwari, Phool Chandra, Sunil Kumar Kadiri
Exploring Progressive Multiple Sclerosis and the Therapeutic Potential of BTK Inhibitors Based on EBV-driven B Cell–microglia Interactions
Leiyun Huang, Jinghan Hu, Song Pang, Yu Zhang, Yifan Wang, Yongzhen Liu, Shangwei Wu, Qingjin Cai, Tianqing Xiong, Jing Qian
Frequently asked questions
How long does it take to publish?
Quick Track allows online publication within 2 weeks of receipt of final approved galley proofs. Total publication time from first receipt of the manuscript to online publication is 10 weeks under Quick Track, subject to acceptance and author revision within one week. Revised papers are usually requested within 15 days, and the time frame for revision may vary from one to four weeks.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite PremiumIs a cover letter required?
A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite PremiumWhat are the publication costs?
Publication is supported by an Article Processing Charge (APC).
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium